Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Light Sciences Oncology completes enrollment in phase III Aptocine trial in MCRC

March 4, 2010

Seattle Genetics achieves milestone under antibody-drug conjugate collaboration with Genentech

March 4, 2010

Celsion to begin phase II trial of ThermoDox and RFA for colorectal liver metastases

March 3, 2010

FDA reschedules meeting on ChemGenex's application for Omapro in CML

March 3, 2010

Synta resumes clinical development of elesclomol

March 3, 2010

Bayer Schering claims new polo-like kinase 1 inhibitors

March 3, 2010

Rigel identifies AXL kinase inhibitors for cancer therapy

March 3, 2010

FDA requests Vion conduct phase II trial of Onrigin in AML prior to phase III study

March 2, 2010

Ariad's AP-24534 receives orphan drug status for CML

March 2, 2010

COMP grants perifosine positive opinion as orphan medicinal product in MM

March 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...